Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discusses the urgent need for more effective ...
Hosted on MSN
New dna test predicts dangerous heart rhythms early
Genetic testing is moving from predicting heart attacks years down the line to flagging dangerous heart rhythms before they ever appear on an electrocardiogram. Instead of waiting for symptoms, ...
Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas ...
In a new Northwestern Medicine study, scientists have developed a more precise genetic risk score to determine whether a person is likely to develop arrhythmia, an irregular heartbeat that can lead to ...
Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...
Younger people who experience sudden cardiac arrest are more likely to have a genetic cause than older people who experience it, according to the Smidt Heart Institute at Cedars-Sinai. The study, ...
Austin, Texas, June 18th, 2026, FinanceWireCardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, ...
Fourth generation Coloradan Nate Drinkwine didn't find out that he had the heart condition hypertrophic cardiomyopathy until his mid-20s. Fourth generation Coloradan Nate Drinkwine didn't find out ...
Expands Coverage Of Precision Cardiovascular Tests Through Atlas Healthcare Physicians. Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results